Table: Brightpath Biotherapeutics - 9-MTH group results

BrightPath Biotherapeutics Co

14/02/2018 06:01

Feb 14 (Reuters)-  
             Brightpath Biotherapeutics Co., Ltd.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended        Year to   
                Dec 31, 2017        Dec 31, 2016      Mar 31, 2018   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales            246 mln             431 mln           280 mln     
                 (-42.8 pct)                           (-47.1 pct)   
  Operating       loss 1.17         loss 699 mln        loss 2.00    
  Recurring       loss 1.17         loss 711 mln        loss 2.00    
  Net             loss 1.18         loss 712 mln        loss 2.00    
  EPS          loss 31.52 yen      loss 21.45 yen    loss 53.73 yen  
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
   
  NOTE - Brightpath Biotherapeutics Co., Ltd..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T 
  ((Tokyo Headline News Desk +813 6441 1812))